Reply to correspondence on "MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation" [0.03%]
关于“通过促进TRIB3介导的FOXO1降解MET促进肝细胞癌的发展”的来信回复
Ji Eun Han,Soon Sun Kim,Jae Youn Cheong et al.
Ji Eun Han et al.
Distinct Inflammatory Imprint in Non-Cirrhotic and Cirrhotic Patients Before and After Direct-Acting Antiviral Therapy [0.03%]
直接抗病毒治疗前後非肝硬化和肝硬化患者独特的炎症印记
Moana Witte,Carlos Oltmanns,Jan Tauwaldt et al.
Moana Witte et al.
Background/aims: Hepatitis C virus (HCV) infection remains a global health challenge, leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC). Despite the high efficacy of direct-acting antiviral (...
Genome-wide interaction study with BMI identifies CYP7A1 and GIPR as genetic modulators of MASLD [0.03%]
基于BMI的全基因组互作研究鉴定出CYP7A1和GIPR是MASLD的遗传调节因子
Oveis Jamialahmadi,Endrina Mujica,Lowri Morris et al.
Oveis Jamialahmadi et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) may progress to liver inflammation, fibrosis, cirrhosis and hepatocellular carcinoma. So far, genome-wide association studies explain a small fr...
Reply to correspondence on "Unveiling TRIB3: A New Mediator in MET-Driven Hepatocellular Carcinoma Progression [0.03%]
关于“揭开TRIB3神秘面纱：MET驱动的肝细胞癌进展新介质”的来信回复
Many Sze Man Chan,Terence Kin Wah Lee
Many Sze Man Chan
Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma [0.03%]
揭秘MET-TRIB3-FOXO1轴：一种新的肝细胞癌驱动靶点
Ji Eun Han,Soon Sun Kim,Jae Youn Cheong et al.
Ji Eun Han et al.
Correspondence: Response to Editorial on "Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma" [0.03%]
关于“揭示MET-TRIB3-FOXO1轴：MET驱动的肝细胞癌新靶点”的编者来信回应
Tiantian Wang,Wenjie Huang,Limin Xia
Tiantian Wang
Advancing Policy and Practice in Alcohol-Associated Liver Disease and Alcohol-Attributable Cancer: Correspondence to the editorial on "Rising Burden of Alcohol-Associated Liver Disease and Cancers: Insights into Sex Disparities and Policy Implications" [0.03%]
关于“酒精相关肝病和癌症负担加剧：性别差异及政策影响的见解”的社论的通信：推动酒精相关肝病和可归因于酒精的癌症领域的政策与实践发展
Pojsakorn Danpanichkul,Donghee Kim,Karn Wijarnpreecha et al.
Pojsakorn Danpanichkul et al.
Reply to correspondence on "A Novel Link Between Tumor Cell Metabolism and Patient Prognosis: Editorial on 'Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway'" [0.03%]
关于“肿瘤细胞代谢与患者预后的新型关联”的来信回复：“基于分区代谢特征和致癌信号通路的肝细胞癌分子分型”的社论答复来信
Eun Ji Jang,Pil Soo Sung
Eun Ji Jang